Evidence map›Paper›PMID 37085971›Full record

ArticleJournal of investigative medicine high impact case reports

Twin Premature Infants With Riboflavin and Biotin Deficiency Presenting With Refractory Lactic Acidosis, Rash, and Multiorgan Failure During Prolonged Parenteral Nutrition.

Mohammad Amin Adie, Maria Martes Gomez, Jessica Yom, Manuel Durand, Fiona Wertheimer, Rachel McGowan, Shoji Yano, Rangasamy Ramanathan

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of investigative medicine high impact case reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mohammad Amin AdieKeck School of Medicine of University of Southern California, LAC+USC Medical Center, Los Angeles, CA, USA.
Maria Martes GomezKeck School of Medicine of University of Southern California, LAC+USC Medical Center, Los Angeles, CA, USA.
Jessica YomKeck School of Medicine of University of Southern California, LAC+USC Medical Center, Los Angeles, CA, USA.
Manuel DurandKeck School of Medicine of University of Southern California, LAC+USC Medical Center, Los Angeles, CA, USA.
Fiona WertheimerKeck School of Medicine of University of Southern California, LAC+USC Medical Center, Los Angeles, CA, USA.
Rachel McGowanKeck School of Medicine of University of Southern California, LAC+USC Medical Center, Los Angeles, CA, USA.
Shoji YanoKeck School of Medicine of University of Southern California, LAC+USC Medical Center, Los Angeles, CA, USA.
Rangasamy RamanathanKeck School of Medicine of University of Southern California, LAC+USC Medical Center, Los Angeles, CA, USA.ORCID 0000-0002-7358-601X
University of Southern California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We are reporting monochorionic, diamniotic twin premature infants born at 25 weeks and 6 days gestation with riboflavin (vitamin B2) and biotin (vitamin B7) deficiency, while on prolonged total parenteral nutrition (TPN) during vitamin shortage. They presented initially with skin rash, lactic acidosis, and thrombocytopenia. Both twins progressed to severe respiratory failure, severe lactic acidosis, with refractory vasodilatory shock, pancytopenia, ischemic bowel injury, acute kidney injury, liver injury, and capillary leak syndrome leading to death of twin A. The surviving twin B was diagnosed with riboflavin and biotin deficiency that presented with abnormal metabolic work up suggestive of maple syrup urine disease, glutaric acidemia type 2, and X-linked adrenoleukodystrophy. Twin B was started on riboflavin and biotin supplementation at 41 days of life, with rapid improvement in clinical findings and laboratory abnormalities within days of starting biotin and riboflavin supplementation. He was discharged home in stable condition at 49 weeks of postmenstrual age.

Indexed as

Acidosis, LacticExanthemaThiamine DeficiencyBiotinBiotinidase DeficiencyHumansInfantInfant, NewbornInfant, PrematureMaleMultiple Organ FailureParenteral NutritionRiboflavinVitaminsBiotinRiboflavinVitaminsbiotinmultiorgan failurepremature infantsriboflavinsevere lactic acidosis

Identifiers

PMID37085971
PMCPMC10126694
OpenAlexW4366742753

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.